INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2015
Net Assets |
£234m |
Net Assets per share |
589p |
Share price |
525p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
97 |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
7.9 |
Regeneron |
7.6 |
Gilead |
7.5 |
Celgene |
7.3 |
Alexion |
4.8 |
Ophthotech |
4.7 |
Biogen |
4.5 |
Vertex |
4.1 |
Incyte |
2.9 |
Anacor |
2.7 |
|
----------- |
Total |
54.0 |
Portfolio Profitability |
% NAV |
Profitable |
51 |
Turning Profitable 2016 |
8 |
Unprofitable |
41 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
84 |
Europe & UK |
16 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
6 JANUARY 2016